ESE logo
ESCO Technologies Inc.(ESE)
Last print unknown agoAbout this dataData status
$251.23▲2.11 (0.85%)Stale · unknown old

ESE Other Current Assets

$174.24MQuarterly · USD

Period ending:

ESE FY Other Current AssetsUSD
ESE FY Other Current Assets1990-09-30: $45.60M1991-09-30: $19.50M1992-09-30: $2.20M1993-09-30: $52.20M1994-09-30: $6.60M1995-09-30: $4.10M1996-09-30: $3.10M1997-09-30: $2.90M1998-09-30: $2.80M1999-09-30: $7.60M2000-09-30: $9.15M2001-09-30: $20.77M2002-09-30: $35.17M2003-09-30: $52.38M2004-09-30: $36.76M2005-09-30: $38.61M2006-09-30: $34.29M2007-09-30: $59.33M2008-09-30: $30.48M2009-09-30: $34.17M2010-09-30: $32.98M2011-09-30: $40.15M2012-09-30: $39.55M2013-09-30: $148.15M2014-09-30: $33.28M2015-09-30: $28.06M2016-09-30: $13.88M2017-09-30: $14.90M2018-09-30: $13.36M2019-09-30: $35.64M2020-09-30: $17.05M2021-09-30: $22.66M2022-09-30: $22.70M2023-09-30: $17.97M2024-09-30: $118.41M2025-09-30: $25.07M$148.15M$0.00
1990-09-302025-09-30

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

ESE other current assets history

Current assets not classified elsewhere. The available annual fiscal periods series contains 36 observations from Sep 30, 1990 to Sep 30, 2025.

Esco Technologies Inc Other Current Assets — Annual fiscal periods (USD)
Period endingOther Current Assets (USD)
25,065,000
118,408,000
17,972,000
22,696,000
22,662,000
17,053,000
35,635,000
13,356,000
14,895,000
13,884,000
28,060,000
33,283,000
148,146,000
39,550,000
40,153,000
32,978,000
34,167,000
30,476,000
59,327,000
34,293,000
38,613,000
36,757,000
52,376,000
35,169,000
20,769,000
9,150,000
7,600,000
2,800,000
2,900,000
3,100,000
4,100,000
6,600,000
52,200,000
2,200,000
19,500,000
45,600,000

Compare other current assets

All ESE financial metrics · ESE stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.